18 Results for "

HFF

" in MedChemExpress (MCE) Product Catalog:
Products (18)

18 Results for "HFF" in MCE Product Catalog:

10
10 Cited Publications
Cat. No.: HY-123937
CAS No.: 2139287-33-3
Purity:  99.16%
Research Areas:  

Infection Cancer

THAL-SNS-032 is a selective CDK9 PROTAC degrader. THAL-SNS-032 recruits CRBN to form a ternary complex with CDK9, thereby triggering ubiquitination and proteasomal degradation of CDK9. THAL-SNS-032 also induces the degradation of CDK1, CDK2 and CDK7. THAL-SNS-032 elevates pH2AX levels, reduces MCL1s expression, and activates caspase-3. THAL-SNS-032 induces cancer cell apoptosis, regulates transcription, and inhibits the replication of human cytomegalovirus (CMV) and SARS-CoV-2. THAL-SNS-032 can be used in research related to breast cancer, leukemia, cytomegalovirus infection and SARS-CoV-2 infection .
loading...
    loading...
Cat. No.: HY-123242
CAS No.: 344900-92-1
Purity:  99.11%
Target:  

Farnesyl Transferase

Research Areas:  

Cancer

FTI-2153 is a potent and highly selective inhibitor of farnesyltransferase (FTase), with an IC50 of 1.4 nM. FTI-2153 is >3000-fold more potent at blocking H-Ras (IC50, 10 nM) than Rap1A processing. Anti-cancer activity .
loading...
    loading...
Cat. No.: HY-16721
CAS No.: 632325-71-4
Synonyms: Filociclovir; ZSM-I-62; MBX-400
Target:  

CMV

Research Areas:  

Infection

Cyclopropavir (Filociclovir) is an orally active and broad-spectrum anti-herpesvirus compound. Cyclopropavir inhibits UL97 kinase activity. Cyclopropavir has antiviral activity against HCMV, MCMV, and HAdV6 viruses .
loading...
    loading...
Cat. No.: HY-147027
CAS No.: 684234-55-7
Purity:  99.48%
PARP-1-IN-2 (compound 11g) is a potent PARP1 inhibitor, with an IC50 of 149 nM, and ADME prediction indicates it has high blood-brain barrier permeability. PARP1-IN-2 shows significantly potent anti-proliferative activity against Human lung adenocarcinoma epithelial cell line A549. PARP1-IN-2 can induce A549 cells apoptosis .
loading...
    loading...
Cat. No.: HY-18771
CAS No.: 175135-47-4
Target:  

Oct3/4

Research Areas:  

Others

O4I1 is an Oct3/4 modulator with activity toward induced-pluripotent stem cell generation.O4I1 enhances Oct3/4 expression, increases Oct3/4 protein levels, and promotes Oct3/4-mediated transcriptional activity.O4I1 can be used for the research of regenerative medicine .
loading...
    loading...
Cat. No.: HY-178335
CAS No.: 3125107-49-2
Target:  

LDLR Wnt CMV

Research Areas:  

Infection

SGC-CK1γ-1 is a potent and selective probe for the CK1γ subfamily. SGC-CK1γ-1 can inhibit LRP6 phosphorylation levels. SGC-CK1γ-1 can selectively inhibit the CK1γ kinases in living cells and inhibit both WNT signaling and human cytomegalovirus (CMV) replication. SGC-CK1γ-1 can be used for the research of infection .
loading...
    loading...
Cat. No.: HY-123242A
CAS No.: 2820151-01-5
Purity:  99.11%
Target:  

Farnesyl Transferase

Research Areas:  

Cancer

FTI-2153 TFA is a potent and highly selective inhibitor of farnesyltransferase (FTase), with an IC50 of 1.4 nM. FTI-2153 TFA is >3000-fold more potent at blocking H-Ras (IC50, 10 nM) than Rap1A processing. Anti-cancer activity .
loading...
    loading...
Cat. No.: HY-155174
CAS No.: 2974488-31-6
Target:  

Akt

Research Areas:  

Cancer

Antiangiogenic agent 4 (Compound 3b) inhibits Akt phosphorylation in HFF and HUVEC cells. Antiangiogenic agent 4 can be used for cancer research .
loading...
    loading...
Cat. No.: HY-147030
CAS No.: 836640-15-4
Purity:  99.29%
Target:  

PARP

Research Areas:  

Cancer

PARP1-IN-8 (compound 11c) is a potent and BBB-penetrated PARP1 inhibitor, with an IC50 of 97 nM. PARP1-IN-8 shows significantly potent anti-proliferative activity against Human lung adenocarcinoma epithelial cell line A549 .
loading...
    loading...
Cat. No.: HY-N12603
Typhatifolin B (Compd 2), an anti-cancer agent, could remarkably induce cell apoptosis and G0/G1 cycle arrest, as well as block cell migration and invasion .
loading...
    loading...
Cat. No.: HY-137889
CAS No.: 347337-33-1
Target:  

CMV

Research Areas:  

Infection

MLS8969 is a selective human cytomegalovirus (HCMV) entry inhibitor with an EC50 of 0.12 μM (HFFs). MLS8969 reduces viral protein levels and inhibits nuclear staining of HCMV pp65. MLS8969 can be used in studies related to human cytomegalovirus infection .
loading...
    loading...
Cat. No.: HY-183009
Target:  

Proteasome Parasite

Research Areas:  

Infection

Pf20S-IN-1 is a selective inhibitor of the 20S proteasome β5 subunit of Plasmodium falciparum. Pf20S-IN-1 exhibits antiparasitic activity against Plasmodium falciparum, with an EC50 of 20.1 nM against the Plasmodium falciparum W2 strain. Pf20S-IN-1 shows weak inhibitory effect on human 20S proteasome, has no obvious toxicity to human foreskin fibroblasts (HFF), and has a selectivity index > 25000. Pf20S-IN-1 can be used in malaria research .
loading...
    loading...
Cat. No.: HY-168959
Target:  

Parasite

Research Areas:  

Infection

Antiparasitic agent-25 (Compounds 11) is an orally active antiparasitic agent. Antiparasitic agent-25 inhibits both parasite invasion and replication ability and has irreversible action against Toxoplasma gondii, significantly reducing the replication rate of Toxoplasma gondii with an IC50 value of 6.33 μM, and demonstrates low cytotoxicity with a CC50 value of 285 μM .
loading...
    loading...
Cat. No.: HY-181586
CAS No.: 1397706-29-4
Target:  

Casein Kinase

Research Areas:  

Others

CK1γ-IN-1 is a non-selective CK1 kinase inhibitor with IC50 values of 780 nM, 570 nM and 990 nM against human CK1γ1, CK1γ2, CK1γ3, respectively. The non-specific binding of CK1γ-IN-1 to multiple kinases enables its application in biological studies of specific CK1γ .
loading...
    loading...
Cat. No.: HY-184426
Target:  

Parasite

Research Areas:  

Infection

TgCDPK1-IN-1 is an orally active, blood-brain barrier-permeable TgCDPK1 inhibitor (IC50 = 15.7 nM) with antiparasitic activity against Toxoplasma gondii. TgCDPK1-IN-1 inhibits Src and TgCDPK G128M. TgCDPK1-IN-1 cures acute toxoplasmosis in immunocompetent mice and prolongs the survival of immunocompromised mice. TgCDPK1-IN-1 is applicable for research related to toxoplasmosis .
loading...
    loading...
Cat. No.: HY-183286
Research Areas:  

Infection

DHFR-IN-27 (Compound LA4) is an orally active DHFR inhibitor and antimalarial agent, with a Ki value of 1.71 nM against TgDHFR. DHFR-IN-27 reduces the parasitic load of Toxoplasma gondii in infected mice and prolongs the survival time of infected mice. DHFR-IN-27 exerts Antiparasitic effects against Toxoplasma gondii. DHFR-IN-27 can be used in the research of toxoplasmosis .
loading...
    loading...
Cat. No.: HY-179260A
PDLLA3000-mPEG2000, PDI≤1.25 is an amphiphilic block copolymer composed of methoxy poly(ethylene glycol) and poly(D,L-lactide). PDLLA3000-mPEG2000, PDI≤1.25 functions as a self-assembled polymeric micelle component to enhance aqueous solubility and oral bioavailability in bioactive substances. PDLLA3000-mPEG2000, PDI≤1.25 can be used in the study of drug delivery .
loading...
    loading...
Cat. No.: HY-186273
CAS No.: 848217-46-9
Target:  

CMV

Research Areas:  

Infection

MLS8091 is a highly selective inhibitor of the human cytomegalovirus (HCMV) helicase-primase complex with antiviral activity. MLS8091 inhibits HCMV replication during the early and late stages of the virus, and suppresses viral DNA replication as well as all HCMV viral proteins. MLS8091 inhibits guinea pig cytomegalovirus replication, and exerts an additive effect when combined with Letermovir (HY-15233). MLS8091 can be used in studies related to human cytomegalovirus infection .
loading...
    loading...
  • 1